Narendra Modi launches vaccination drive against COVID-19, says campaign will ensure 'decisive victory' over pandemic

Modi reminded people that two doses of vaccine are very important and asked them to keep wearing masks and maintain social distancing even after receiving the jabs

Press Trust of India January 16, 2021 13:13:01 IST
Narendra Modi launches vaccination drive against COVID-19, says campaign will ensure 'decisive victory' over pandemic

Narendra Modi speaking at the launch of India's vaccination drive against the novel coronavirus. ANI

New Delhi: Prime Minister Narendra Modi on Saturday launched India's COVID-19 vaccination drive and asserted that the made-in-India vaccines being rolled out will ensure a "decisive victory" for the country over the coronavirus pandemic.

Addressing the nation ahead of the launch, Modi reminded people that two doses of vaccine are very important and asked them to maintain wearing masks and social distancing even after receiving the jabs.

During his speech, Modi turned emotional as he spoke of the disruption the pandemic caused to people's lives, isolating victims of the coronavirus and denying the dead traditional last rites.

In a choked voice, the prime minister also referred to sacrifices made by healthcare and frontline workers, hundreds of whom lost their lives to the viral infection.

He also urged the country to show patience during the vaccination drive as it had shown till now in fighting the pandemic.

Normally, it takes years to make a vaccine but in such a short span of time, not one, but two 'Made in India' vaccines are ready, Modi said, adding work on other vaccines is also progressing at a fast pace.

India getting two vaccines in such a short time is a testimony to the talent and skills of the nation's scientists, the prime minister said.

"Our vaccination programme is driven by humanitarian concerns, those exposed to maximum risk will get priority," he said.

Modi said that scientists and experts have given permission for emergency use of the made-in-India vaccines only after being absolutely sure of their safety and the people should be aware of any propaganda and rumours.

The made-in-India vaccines will ensure a "decisive victory" for the country over the coronavirus pandemic, he asserted.

The Drugs Controller General of India (DCGI) had earlier this month approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.

This will be the world's largest vaccination programme covering the entire length and breadth of the country.

According to the government, the shots will be offered first to an estimated one crore healthcare workers, and around two crore frontline workers, and then to persons above 50 years of age, followed by persons younger than 50 years of age with associated comorbidities.

Cost of vaccination of healthcare and frontline workers will be borne by the central government.

Updated Date:

Subscribe to Moneycontrol Pro at ₹499 for the first year. Use code PRO499. Limited period offer. *T&C apply

also read

COVID-19 in UK: Officials hunt for 'missing' person carrying Brazilian strain as experts sound alarm
World

COVID-19 in UK: Officials hunt for 'missing' person carrying Brazilian strain as experts sound alarm

The variant that emerged in northern Brazil has been detected in six people in the UK, one of whom cannot be located after they failed to fill in their contact details on a form after taking a coronavirus test

Medical teams in Turkey travel to remote mountain villages as part of vaccination drive against coronavirus
long reads

Medical teams in Turkey travel to remote mountain villages as part of vaccination drive against coronavirus

After traveling snow and ice covered roads, medical workers arrived in the small settlement of 350 people some 140 miles (230 kilometres) from the provincial capital, to vaccinate older villagers.

AstraZeneca vaccine has higher efficacy against COVID-19 with a three-month gap between doses, says Oxford study
Health

AstraZeneca vaccine has higher efficacy against COVID-19 with a three-month gap between doses, says Oxford study

The study, published in The Lancet, suggests that the interval between doses can be safely extended to three months than a six-week gap as the first dose can offer up to 76 percent protection during that period